ReviewAdvanced drug delivery reviews2021

Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation.

Nikolaos Batis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.